[go: up one dir, main page]

CN1962651A - Preparation process of key intermediate 5-cyanphthalide of antidepressant drug citalopram - Google Patents

Preparation process of key intermediate 5-cyanphthalide of antidepressant drug citalopram Download PDF

Info

Publication number
CN1962651A
CN1962651A CN 200610154721 CN200610154721A CN1962651A CN 1962651 A CN1962651 A CN 1962651A CN 200610154721 CN200610154721 CN 200610154721 CN 200610154721 A CN200610154721 A CN 200610154721A CN 1962651 A CN1962651 A CN 1962651A
Authority
CN
China
Prior art keywords
bromophthalide
cyanophthalide
cuprous iodide
key intermediate
sodium cyanide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200610154721
Other languages
Chinese (zh)
Other versions
CN100457747C (en
Inventor
徐方羲
林旭锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CNB2006101547213A priority Critical patent/CN100457747C/en
Publication of CN1962651A publication Critical patent/CN1962651A/en
Application granted granted Critical
Publication of CN100457747C publication Critical patent/CN100457747C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺。它是以烷基苯为反应溶剂,以碘化亚铜、碘化钾和N,N’-二甲基乙二胺为组合催化剂,5-溴苯酞和氰化钠在氮气保护下在100~150℃反应20~48小时,随后减压回收溶剂,接着加入水,过滤,水洗,最后滤出物用乙醇重结晶分离得到5-氰基苯酞,5-溴苯酞和氰化钠的摩尔当量比例为1∶1.0~2.0;碘化亚铜的用量为5-溴苯酞的5~30%摩尔当量,碘化钾的用量为碘化亚铜的1.5~3摩尔当量;N,N’-二甲基乙二胺的用量为5-溴苯酞的1~1.5摩尔当量。本发明具有以下优点:1)反应条件温和;2)反应工艺流程短;3)使用廉价的试剂;4)投料和后处理都非常简单,易于实现工业化大生产。The invention discloses a preparation process of the key intermediate 5-cyanophthalide of the antidepressant citalopram. It uses alkylbenzene as the reaction solvent, cuprous iodide, potassium iodide and N, N'-dimethylethylenediamine as the combined catalyst, 5-bromophthalide and sodium cyanide under the protection of nitrogen at 100-150 React at ℃ for 20-48 hours, then recover the solvent under reduced pressure, then add water, filter, wash with water, and finally the filtrate is separated by recrystallization with ethanol to obtain the molar equivalents of 5-cyanophthalide, 5-bromophthalide and sodium cyanide The ratio is 1:1.0~2.0; the dosage of cuprous iodide is 5~30% molar equivalent of 5-bromophthalide, the dosage of potassium iodide is 1.5~3 molar equivalent of cuprous iodide; N,N'-dimethyl The consumption of ethylenediamine is 1~1.5 molar equivalents of 5-bromophthalide. The invention has the following advantages: 1) mild reaction conditions; 2) short reaction process flow; 3) use of cheap reagents; 4) very simple feeding and post-treatment, easy to realize large-scale industrial production.

Description

抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺Preparation process of key intermediate 5-cyanophthalide of antidepressant citalopram

技术领域technical field

本发明涉及医药中间体制备方法,尤其涉及一种抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺。The invention relates to a preparation method of a pharmaceutical intermediate, in particular to a preparation process of a key intermediate of citalopram, an antidepressant, 5-cyanophthalide.

背景技术Background technique

5一氰基苯酞(5-Cyano-phthalide)的化学名为1,3-二氢-1-氧-5-异苯并呋喃腈,是合成抗抑郁药西酞普兰(Citalopram)的关键中间体。因此如何高效地合成5一氰基苯酞受到人们的巨大关注。5一氰基苯酞的合成已有一些文献报道,比如文献WO00112044,2000-03-09报道以苯二甲酸和多聚甲醛为起始原料在发烟硫酸作用下制得5一羧基苯酞,经氯化亚砜酰氯化、氨水酰胺化和环丁砜脱水等反应而制得。文献《化学与生物工程》2006,Vo1.23,No.6,17-18和《中国医药工业杂志》2004,35(6),330-331等以邻苯二甲酰亚胺为起始原料经过硝化、还原、环合、Sandmeyer氰化反应,合成了5一氰基苯酞。文献CN1379025报道以5-羧基苯酞为起始原料,与无机氨或无机铵盐或小分子量有机酸铵盐反应得到相应的5-苯酞甲酸铵盐,5-苯酞甲酸铵盐,在溶剂和催化剂存在的条件下,经脱水剂脱水反应制得5-氰基苯酞。文献CN1331686报道将5-羧基2-苯并[c]呋喃酮转化为相应的酰胺,然后和脱水剂反应,得到5一氰基苯酞。上述这些合成工艺反应流程周期时间长,条件苛刻,或有不少实验过程涉及强酸或强碱条件、低产率、后处理复杂等种种问题。因而,在温和的条件下,高效的解决5一氰基苯酞的合成是非常重要和迫切的。The chemical name of 5-cyanophthalide (5-Cyano-phthalide) is 1,3-dihydro-1-oxo-5-isobenzofuranonitrile, which is the key intermediate for the synthesis of antidepressant citalopram. body. Therefore, how to efficiently synthesize 5-cyanophthalide has attracted great attention. The synthesis of 5-cyanophthalide has been reported in some literatures. For example, the document WO00112044, 2000-03-09 reported that 5-carboxyphthalide was prepared by using phthalic acid and paraformaldehyde as starting materials under the action of oleum. It can be prepared by thionyl chloride chlorination, amidation of ammonia and dehydration of sulfolane. Literature "Chemical and Biological Engineering" 2006, Vo1.23, No.6, 17-18 and "Chinese Journal of Pharmaceutical Industry" 2004, 35(6), 330-331, etc. use phthalimide as the starting material After nitration, reduction, cyclization and Sandmeyer cyanation reaction, 5-cyanophthalide was synthesized. Document CN1379025 reports to be starting raw material with 5-carboxyphthalide, reacts with inorganic ammonia or inorganic ammonium salt or small molecular weight organic acid ammonium salt to obtain corresponding 5-phthalide ammonium formate, 5-phthalide ammonium formate, in solvent In the presence of a catalyst, 5-cyanophthalide can be obtained through the dehydration reaction of a dehydrating agent. Document CN1331686 reports that 5-carboxy 2-benzo[c]furanone is converted into the corresponding amide, and then reacted with a dehydrating agent to obtain 5-cyanophthalide. The reaction process of the above-mentioned synthetic processes has a long cycle time and harsh conditions, or many experimental processes involve strong acid or strong alkali conditions, low yield, complicated post-treatment and other problems. Therefore, under mild conditions, it is very important and urgent to efficiently solve the synthesis of 5-cyanophthalide.

发明内容Contents of the invention

本发明的目的是提供一种抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺。The object of the present invention is to provide a kind of preparation technology of antidepressant citalopram key intermediate 5-cyanophthalide.

它是以烷基苯为反应溶剂,以碘化亚铜、碘化钾和N,N’-二甲基乙二胺为组合催化剂,5-溴苯酞和氰化钠在氮气保护下在100~150℃反应20~48小时,随后减压回收溶剂,接着加入水,过滤,水洗,最后滤出物用乙醇重结晶分离得到5-氰基苯酞,5-溴苯酞和氰化钠的摩尔当量比例为1∶1.0~2.0;碘化亚铜的用量为5-溴苯酞的5~30%摩尔当量,碘化钾的用量为碘化亚铜的1.5~3摩尔当量;N,N’-二甲基乙二胺的用量为5-溴苯酞的1~1.5摩尔当量,反应式为:It uses alkylbenzene as the reaction solvent, cuprous iodide, potassium iodide and N, N'-dimethylethylenediamine as the combined catalyst, 5-bromophthalide and sodium cyanide under the protection of nitrogen at 100 to 150 ℃ for 20 to 48 hours, then recover the solvent under reduced pressure, then add water, filter, wash with water, and finally recrystallize the filtrate with ethanol to obtain the molar equivalents of 5-cyanophthalide, 5-bromophthalide and sodium cyanide The ratio is 1:1.0~2.0; the consumption of cuprous iodide is 5~30% molar equivalent of 5-bromophthalide, the consumption of potassium iodide is 1.5~3 molar equivalent of cuprous iodide; N, N'-dimethyl The consumption of ethylenediamine is 1~1.5 molar equivalents of 5-bromophthalide, and the reaction formula is:

所述的反应溶剂烷基苯为甲苯、乙苯或二甲苯。反应时间优选为20~36小时。反应温度优选为100~130℃。5-溴苯酞和氰化钠的摩尔当量比例优选为1∶1.0~1.5;碘化亚铜的用量为5-溴苯酞的5~20%摩尔当量;碘化钾的用量优选为碘化亚铜的1.5~2.5摩尔当量;N,N’-二甲基乙二胺的用量优选为5-溴苯酞的1~1.2摩尔当量。The reaction solvent alkylbenzene is toluene, ethylbenzene or xylene. The reaction time is preferably 20 to 36 hours. The reaction temperature is preferably 100 to 130°C. The molar equivalent ratio of 5-bromophthalide and sodium cyanide is preferably 1: 1.0~1.5; The consumption of cuprous iodide is 5~20% molar equivalent of 5-bromophthalide; The consumption of potassium iodide is preferably cuprous iodide 1.5-2.5 molar equivalents of N, N'-dimethylethylenediamine is preferably 1-1.2 molar equivalents of 5-bromophthalide.

本发明与已有的合成方法相比,具有以下优点:Compared with existing synthetic methods, the present invention has the following advantages:

1)反应条件温和;1) mild reaction conditions;

2)反应工艺流程短;2) The reaction process flow is short;

3)使用廉价的试剂;3) Use cheap reagents;

4)投料和后处理都非常简单,易于实现工业化大生产。4) Feeding and post-processing are very simple, and it is easy to realize industrialized large-scale production.

具体实施方式Detailed ways

5-氰基苯酞的分子式为:The molecular formula of 5-cyanophthalide is:

Figure A20061015472100042
Figure A20061015472100042

抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺的具体反应步骤如下:The specific reaction steps of the preparation technology of antidepressant citalopram key intermediate 5-cyanophthalide are as follows:

以烷基苯为反应溶剂,以碘化亚铜、碘化钾和N,N’-二甲基乙二胺为组合催化剂,5-溴苯酞和氰化钠在氮气保护下在100~150℃反应20~48小时,随后减压回收溶剂,接着加入水,过滤,水洗,最后滤出物用乙醇重结晶分离得到高产率、高纯度的5-氰基苯酞。其中5-溴苯酞和氰化钠的摩尔当量比例为1∶1.0~2.0;碘化亚铜的用量为5-溴苯酞的5~30%摩尔当量;碘化钾的用量为碘化亚铜的1.5~3摩尔当量;N,N’-二甲基乙二胺的用量为5-溴苯酞的1-1.5摩尔当量。推荐反应溶剂烷基苯为甲苯、乙苯、二甲苯,最优先为甲苯。推荐反应时间为20~36小时,最优先为24小时。推荐反应温度为100~130℃,最优先为110℃。推荐5-溴苯酞和氰化钠的摩尔当量比例为1∶1.0~1.5,最优先为1∶1.2;碘化亚铜的用量为5-溴苯酞的5~20%摩尔当量,最优先为10%摩尔当量;碘化钾的用量为碘化亚铜的1.5~2.5摩尔当量,最优先为2摩尔当量;N,N’-二甲基乙二胺用量为5-溴苯酞的1~1.2摩尔当量,最优先为1摩尔当量。以下实施例将有助于理解本发明,但不限于本发明的内容:With alkylbenzene as the reaction solvent, cuprous iodide, potassium iodide and N,N'-dimethylethylenediamine as the combined catalyst, 5-bromophthalide and sodium cyanide react at 100-150°C under nitrogen protection After 20 to 48 hours, the solvent is recovered under reduced pressure, then water is added, filtered, washed with water, and finally the filtrate is recrystallized with ethanol and separated to obtain 5-cyanophthalide with high yield and high purity. Wherein the molar equivalent ratio of 5-bromophthalide and sodium cyanide is 1: 1.0~2.0; The consumption of cuprous iodide is 5~30% molar equivalent of 5-bromophthalide; The consumption of potassium iodide is the amount of cuprous iodide 1.5-3 molar equivalents; the amount of N,N'-dimethylethylenediamine is 1-1.5 molar equivalents of 5-bromophthalide. The recommended reaction solvent alkylbenzene is toluene, ethylbenzene, xylene, and toluene is the most preferred. The recommended response time is 20 to 36 hours, with 24 hours being the most preferred. The recommended reaction temperature is 100-130°C, most preferably 110°C. It is recommended that the molar equivalent ratio of 5-bromophthalide and sodium cyanide is 1:1.0~1.5, the most preferred is 1:1.2; the amount of cuprous iodide is 5-20% molar equivalent of 5-bromophthalide, the most preferred 10% molar equivalent; the dosage of potassium iodide is 1.5-2.5 molar equivalents of cuprous iodide, the most preferred is 2 molar equivalents; the dosage of N,N'-dimethylethylenediamine is 1-1.2 molar equivalents of 5-bromophthalide Molar equivalent, most preferably 1 molar equivalent. The following examples will help to understand the present invention, but are not limited to the content of the present invention:

实施例1Example 1

在100毫升三颈瓶中,氮气保护下依次加入50毫升甲苯,6.4克(30毫摩尔)5-溴苯酞,1.18克(36毫摩尔,1.2当量)氰化钠,0.573克(3毫摩尔,0.1当量)碘化亚铜,1克碘化钾(6毫摩尔,0.2当量),2.64克N,N’-二甲基乙二胺(30毫摩尔,1.0当量),在氮气保护下在110℃搅拌反应30小时,结束反应,减压回收溶剂甲苯,残留物接着加入50毫升水,室温搅拌1小时,过滤,水洗,最后滤出物用乙醇重结晶分离得到白色针状晶体5-氰基苯酞,产率90%,纯度98%(HPLC),熔点200~202℃。1HNMR(CDCl3,ppm):5.51(2H,s),7.55(1H,s),7.55(1H,s),8.05(1H,d,J=2.5Hz).In a 100 ml three-necked flask, 50 ml of toluene, 6.4 g (30 mmol) of 5-bromophthalide, 1.18 g (36 mmol, 1.2 equivalents) of sodium cyanide, 0.573 g (3 mmol) of sodium cyanide were added successively under nitrogen protection. , 0.1 equivalent) cuprous iodide, 1 gram of potassium iodide (6 mmol, 0.2 equivalent), 2.64 grams of N, N'-dimethylethylenediamine (30 mmol, 1.0 equivalent), under nitrogen protection at 110 ° C Stir the reaction for 30 hours, end the reaction, recover the solvent toluene under reduced pressure, then add 50 ml of water to the residue, stir at room temperature for 1 hour, filter, wash with water, and finally the filtrate is separated by recrystallization with ethanol to obtain white needle-shaped crystals of 5-cyanobenzene Phthale, the yield is 90%, the purity is 98% (HPLC), and the melting point is 200-202°C. 1 HNMR (CDCl 3 , ppm): 5.51 (2H, s), 7.55 (1H, s), 7.55 (1H, s), 8.05 (1H, d, J=2.5Hz).

实施例2Example 2

在100毫升三颈瓶中,氮气保护下依次加入60毫升乙苯,6.4克(30毫摩尔)5-溴苯酞,1.6克(39毫摩尔,1.3当量)氰化钠,0.573克(3毫摩尔,0.1当量)碘化亚铜,1克碘化钾(6毫摩尔,0.2当量),2.64克N,N’-二甲基乙二胺(30毫摩尔,1.0当量),在氮气保护下在130℃搅拌反应24小时,结束反应,减压回收溶剂乙苯,残留物接着加入50毫升水,室温搅拌1小时,过滤,水洗,最后滤出物用乙醇重结晶分离得到白色针状晶体5-氰基苯酞,产率85%,纯度99%,熔点201~202℃。In a 100 ml three-necked flask, 60 ml of ethylbenzene, 6.4 g (30 mmol) of 5-bromophthalide, 1.6 g (39 mmol, 1.3 equivalents) of sodium cyanide, 0.573 g (3 mg) of sodium cyanide were added successively under nitrogen protection. mol, 0.1 equivalent) cuprous iodide, 1 gram of potassium iodide (6 mmol, 0.2 equivalent), 2.64 grams of N, N'-dimethylethylenediamine (30 mmol, 1.0 equivalent), under nitrogen protection at 130 Stir the reaction at ℃ for 24 hours, end the reaction, recover the solvent ethylbenzene under reduced pressure, then add 50 ml of water to the residue, stir at room temperature for 1 hour, filter, wash with water, and finally the filtrate is separated by recrystallization from ethanol to obtain white needle-shaped crystals of 5-cyanide phenylphthalide, the yield is 85%, the purity is 99%, and the melting point is 201-202°C.

实施例3Example 3

在100毫升三颈瓶中,氮气保护下依次加入50毫升甲苯,6.4克(30毫摩尔)5-溴苯酞,1.18克(36毫摩尔,1.2当量)氰化钠,0.7克(4.5毫摩尔,0.15当量)碘化亚铜,1.5克碘化钾(9毫摩尔,0.3当量),2.64克N,N’-二甲基乙二胺(30毫摩尔,1.0当量),在氮气保护下在100℃搅拌反应48小时,结束反应,减压回收溶剂甲苯,残留物接着加入50毫升水,室温搅拌1小时,过滤,水洗,最后滤出物用乙醇重结晶分离得到白色针状晶体5-氰基苯酞,产率91%,纯度98%,熔点200~202℃。In a 100 ml three-necked flask, 50 ml of toluene, 6.4 g (30 mmol) of 5-bromophthalide, 1.18 g (36 mmol, 1.2 equivalents) of sodium cyanide, 0.7 g (4.5 mmol) of sodium cyanide were added successively under nitrogen protection. , 0.15 equivalents) cuprous iodide, 1.5 grams of potassium iodide (9 mmoles, 0.3 equivalents), 2.64 grams of N, N'-dimethylethylenediamine (30 mmoles, 1.0 equivalents), under nitrogen protection at 100 ° C Stir the reaction for 48 hours, end the reaction, recover the solvent toluene under reduced pressure, then add 50 ml of water to the residue, stir at room temperature for 1 hour, filter, wash with water, and finally the filtrate is separated by recrystallization with ethanol to obtain white needle-shaped crystals of 5-cyanobenzene Phthale, the yield is 91%, the purity is 98%, and the melting point is 200-202°C.

实施例4Example 4

在100毫升三颈瓶中,氮气保护下依次加入60毫升二甲苯,6.4克(30毫摩尔)5-溴苯酞,2.5克(60毫摩尔,2当量)氰化钠,1.7克(9毫摩尔,0.3当量)碘化亚铜,2克碘化钾(12毫摩尔,0.4当量),3.6克N,N’-二甲基乙二胺(45毫摩尔,1.5当量),在氮气保护下在150℃搅拌反应20小时,结束反应,减压回收溶剂乙苯,残留物接着加入50毫升水,室温搅拌1小时,过滤,水洗,最后滤出物用乙醇重结晶分离得到白色针状晶体5-氰基苯酞,产率83%,纯度99%,熔点201~202℃。In a 100 ml three-necked flask, 60 ml of xylene, 6.4 g (30 mmol) of 5-bromophthalide, 2.5 g (60 mmol, 2 equivalents) of sodium cyanide, 1.7 g (9 mg) of sodium cyanide were added successively under nitrogen protection. Moles, 0.3 equivalents) cuprous iodide, 2 grams of potassium iodide (12 mmoles, 0.4 equivalents), 3.6 grams of N, N'-dimethylethylenediamine (45 mmoles, 1.5 equivalents), under nitrogen protection at 150 Stir the reaction at ℃ for 20 hours, end the reaction, recover the solvent ethylbenzene under reduced pressure, then add 50 ml of water to the residue, stir at room temperature for 1 hour, filter, wash with water, and finally the filtrate is separated by recrystallization with ethanol to obtain white needle-shaped crystals of 5-cyanide phenylphthalide, the yield is 83%, the purity is 99%, and the melting point is 201-202°C.

实施例5Example 5

在100毫升三颈瓶中,氮气保护下依次加入50毫升甲苯,6.4克(30毫摩尔)5-溴苯酞,1.0克(30毫摩尔,1.0当量)氰化钠,0.7克(4.5毫摩尔,0.15当量)碘化亚铜,1.5克碘化钾(9毫摩尔,0.3当量),2.64克N,N’-二甲基乙二胺(30毫摩尔,1.0当量),在氮气保护下在105℃搅拌反应48小时,结束反应,减压回收溶剂甲苯,残留物接着加入50毫升水,室温搅拌1小时,过滤,水洗,最后滤出物用乙醇重结晶分离得到白色针状晶体5-氰基苯酞,产率86%,纯度98%,熔点200~202℃。In a 100 ml three-necked flask, 50 ml of toluene, 6.4 g (30 mmol) of 5-bromophthalide, 1.0 g (30 mmol, 1.0 equivalent) of sodium cyanide, 0.7 g (4.5 mmol) of sodium cyanide were added successively under nitrogen protection. , 0.15 equivalents) cuprous iodide, 1.5 grams of potassium iodide (9 mmoles, 0.3 equivalents), 2.64 grams of N, N'-dimethylethylenediamine (30 mmoles, 1.0 equivalents), under nitrogen protection at 105 ° C Stir the reaction for 48 hours, end the reaction, recover the solvent toluene under reduced pressure, then add 50 ml of water to the residue, stir at room temperature for 1 hour, filter, wash with water, and finally the filtrate is separated by recrystallization with ethanol to obtain white needle-shaped crystals of 5-cyanobenzene Phthalophthalein, the yield is 86%, the purity is 98%, and the melting point is 200-202°C.

Claims (5)

1.一种抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺,其特征在于它是以烷基苯为反应溶剂,以碘化亚铜、碘化钾和N,N’-二甲基乙二胺为组合催化剂,5-溴苯酞和氰化钠在氮气保护下在100~150℃反应20~48小时,随后减压回收溶剂,接着加入水,过滤,水洗,最后滤出物用乙醇重结晶分离得到5-氰基苯酞,5-溴苯酞和氰化钠的摩尔当量比例为1∶1.0~2.0;碘化亚铜的用量为5-溴苯酞的5~30%摩尔当量,碘化钾的用量为碘化亚铜的1.5~3摩尔当量;N,N’-二甲基乙二胺的用量为5-溴苯酞的1~1.5摩尔当量,反应式为:1. A preparation process of antidepressant citalopram key intermediate 5-cyanophthalide, characterized in that it is a reaction solvent with alkylbenzene, cuprous iodide, potassium iodide and N, N'-di Methylethylenediamine is the combined catalyst, 5-bromophthalide and sodium cyanide are reacted at 100-150°C under nitrogen protection for 20-48 hours, then the solvent is recovered under reduced pressure, then water is added, filtered, washed with water, and finally filtered out The material is recrystallized and separated with ethanol to obtain 5-cyanophthalide, and the molar equivalent ratio of 5-bromophthalide and sodium cyanide is 1: 1.0~2.0; the consumption of cuprous iodide is 5~30 of 5-bromophthalide. % molar equivalent, the consumption of potassium iodide is 1.5~3 molar equivalents of cuprous iodide; the consumption of N, N'-dimethylethylenediamine is 1~1.5 molar equivalents of 5-bromophthalide, and the reaction formula is: 2.根据权利要求1所述的一种抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺,其特征在于所述的反应溶剂烷基苯为甲苯、乙苯或二甲苯。2. the preparation technology of a kind of antidepressant citalopram key intermediate 5-cyanophthalide according to claim 1 is characterized in that described reaction solvent alkylbenzene is toluene, ethylbenzene or xylene. 3.根据权利要求1所述的一种抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺,其特征在于所述的反应时间为20~36小时。3. the preparation technology of a kind of antidepressant citalopram key intermediate 5-cyanophthalide according to claim 1, it is characterized in that described reaction time is 20~36 hours. 4.根据权利要求1所述的一种抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺,其特征在于所述的反应温度为100~130℃。4. the preparation technology of a kind of antidepressant citalopram key intermediate 5-cyanophthalide according to claim 1, it is characterized in that described reaction temperature is 100~130 ℃. 5.根据权利要求1所述的一种抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺,其特征在于所述的5-溴苯酞和氰化钠的摩尔当量比例为1∶1.0~1.5;碘化亚铜的用量为5-溴苯酞的5~20%摩尔当量;碘化钾的用量为碘化亚铜的1.5~2.5摩尔当量;N,N’-二甲基乙二胺的用量为5-溴苯酞的1~1.2摩尔当量。5. the preparation technology of a kind of antidepressant citalopram key intermediate 5-cyanophthalide according to claim 1 is characterized in that the molar equivalent ratio of described 5-bromophthalide and sodium cyanide is 1: 1.0~1.5; the amount of cuprous iodide is 5~20% molar equivalent of 5-bromophthalide; the amount of potassium iodide is 1.5~2.5 molar equivalent of cuprous iodide; The amount of diamine used is 1 to 1.2 molar equivalents of 5-bromophthalide.
CNB2006101547213A 2006-11-21 2006-11-21 Preparation process of key intermediate 5-cyanphthalide of antidepressant drug citalopram Expired - Fee Related CN100457747C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006101547213A CN100457747C (en) 2006-11-21 2006-11-21 Preparation process of key intermediate 5-cyanphthalide of antidepressant drug citalopram

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006101547213A CN100457747C (en) 2006-11-21 2006-11-21 Preparation process of key intermediate 5-cyanphthalide of antidepressant drug citalopram

Publications (2)

Publication Number Publication Date
CN1962651A true CN1962651A (en) 2007-05-16
CN100457747C CN100457747C (en) 2009-02-04

Family

ID=38081897

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006101547213A Expired - Fee Related CN100457747C (en) 2006-11-21 2006-11-21 Preparation process of key intermediate 5-cyanphthalide of antidepressant drug citalopram

Country Status (1)

Country Link
CN (1) CN100457747C (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
WO2001049672A1 (en) * 1999-12-30 2001-07-12 H. Lundbeck A/S Method for the preparation of citalopram
CN1266143C (en) * 2002-04-15 2006-07-26 杭州达康化工有限公司 Process for preparing 5-cynophenyl phthaleine

Also Published As

Publication number Publication date
CN100457747C (en) 2009-02-04

Similar Documents

Publication Publication Date Title
CN113292535B (en) Method for preparing apaluamide intermediate and apaluamide
JP5873484B2 (en) Dronedarone and method for producing the salt thereof
CN102898264A (en) Catalytic preparation process for aromatic nitrile or heteroaromatic nitrile
CN102850325A (en) Preparation method of Dabigatran etexilate key intermediate
CN107469825A (en) A kind of preparation method and application of the nickel-based multimetallic catalyst of the carbon nanotube loaded bimetallic copper magnesium codope of oxidation modification
CN101337895B (en) Method for preparing 2,2'-di(trifluoromethyl)-4,4'-benzidine
CN106854165B (en) A kind of preparation method of the bis- halogenated m-dicyanobenzenes of 4,6-
CN102093289A (en) New preparation method of Blonanserin intermediate
CN102126977A (en) Method for preparing 5-aminosalicylic acid by adopting gas phase catalysis carboxylation method
CN113402466B (en) Apaglucone intermediate and method for preparing apalone
CN1962651A (en) Preparation process of key intermediate 5-cyanphthalide of antidepressant drug citalopram
CN100516058C (en) Synthetic process of 5-cyanophthalide
CN102746185A (en) Preparation process of aromatic nitrile compound
CN103204810B (en) A kind of tolvaptan intermediate and preparation method thereof
CN108299466A (en) A kind of improved Du Lutewei synthetic methods
CN104910068A (en) 2-cyano isonicotinic acid hydrazide 1.5 p-toluenesulfonate synthetic method
CN100391952C (en) Process for the preparation of citalopram salt
CN101157674B (en) Purification method of citalopram salt
CN115636764B (en) Synthesis method of benzamide compound
CN102391170A (en) Method for preparing N,N-diallyl-5-methoxytryptamine hydrochlorides
CN102108043A (en) Synthesis method of 1,3,5,7-tetrahydroxyadamantane
CN1978429A (en) Method for treating 4 chloro pyridine in solvent
CN101723889A (en) Method for synthesizing 6-chloropyridine-3-carbonyl chloride
CN100427462C (en) The preparation technology of 2,4-difluorobenzonitrile
CN1332936C (en) Acyl aromatic amine synthesizing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090204

Termination date: 20111121